Archive for MACPAC

 

Federal Health Policy Update for Wednesday, May 5

The following is the latest health policy news from the federal government as of 2:45 p.m. on Wednesday, May 5.  Some of the language used below is taken directly from government documents.

The White House

COVID-19

Department of Health and Human Services

COVID-19

  • HHS has created a web page for its new COVID-19 Coverage Assistance Fund through which providers can be reimbursed for the cost of administering COVID-19 vaccines to the uninsured and to those whose health insurance requires a co-pay for vaccinations.  This web page offers information about how the program works and how providers can submit claims for reimbursement.
  • To support the launch of this new COVID-19 Coverage Assistance Fund, HHS will hold a webinar on Thursday, May 6 at 2:00 p.m. (eastern) to introduce stakeholders to what the program will do and how it will work.  Go here for further information and to register to participate.
  • HHS has announced the availability of $250 million in American Rescue Plan funds to develop and support a community-based workforce that will share information about vaccines, increase COVID-19

Federal Health Policy Update for Tuesday, April 20

The following is the latest health policy news from the federal government as of 3:00 p.m. on Tuesday, April 20.

Congress

  • This afternoon Senator John Cornyn (R-TX) put a hold on the president’s nomination of Chiquita Brooks-LaSure to be CMS administrator in response to the administration’s decision to revoke a Medicaid waiver the previous administration granted to his state.

The White House

COVID-19

Centers for Medicare & Medicaid Services

COVID-19

  • CMS has issued section 1135 waivers to Colorado, Maine, and Tennessee.  1135 waivers give states greater flexibility to serve their Medicaid beneficiaries during the COVID-19 public health emergency.

Department of Health and Human Services

COVID-19

MACPAC Meets

The Medicaid and CHIP Payment and Access Commission met for two days last week in Washington, D.C.

The following is MACPAC’s own summary of the sessions.

MACPAC kicked off its April meeting with a review of a draft chapter for the June 2021 report to Congress and recommendations on addressing high-cost specialty drugs. Since 2017, the Commission has been working to identify potential models that could help states address the challenges of high prices. The presentation focused on drugs that have been approved by the U.S. Food and Drug Administration (FDA) under the accelerated approval pathway. Such approvals are based on whether the drug has an effect on a surrogate endpoint that is reasonably likely to predict a clinical benefit; however, unlike under the traditional pathway, the clinical benefit has yet to be verified.

On Friday, the Commission voted to approve two recommendations* that address Medicaid payment for such drugs. The recommendations would increase the rebates under the Medicaid Drug Rebate Program on accelerated approval drugs until these drugs have verified the clinical benefit. Once the FDA converts the drugs to traditional approval, the rebates would revert back to the standard amounts.

Commissioners then turned their attention to ways states

Health Policy Update for Monday, April 12

The following is the latest health policy news from the federal government as of 2:30 p.m. on Monday, April 12.

The White House

COVID-19

Health Policy and Budget News

  • The Biden administration has released its proposed FY 2022 discretionary budget, which addresses, among other things, many aspects of health care policy.  Find the news release announcing the proposed budget here and the budget document itself here.

Centers for Medicare & Medicaid Services

COVID-19

Proposed Rules

  • CMS has published a special edition of its online publication MLN Connects devoted entirely to its recently published regulations proposing FY 2022 Medicare payments for skilled nursing facilities, hospice providers, inpatient rehabilitation facilities, and inpatient psychiatric facilities.

Centers for Disease Control and Prevention

COVID-19

MACPAC Looks at Recipients of Provider Relief Fund Grants

What kinds of providers did and did not receive grants from the CARES Act’s Provider Relief Fund?  What were the obstacles to receiving those COVID-19 relief grants and why did some providers fare better in the distribution of Provider Relief Fund resources than others?

These questions and more are addressed in “COVID Relief Funding for Medicaid Providers,” a new analysis released by the Medicaid and CHIP Payment and Access Commission.